Company & Sponsor Intelligence

Nantes University Hospital

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials10

Recruiting1

Completed2

Countries1

Therapeutic footprint

adhdalzheimersdepressionother_psychiatryparkinsonsstroke

Indexed studies

NCT06906328MEthylphenidate in ADHD - Addiction(s) Comorbidity: Value of Adding a Cognitive Remediation Program to Improve Short- and Medium-term Therapeutic Response
adhd · FranceNA

NCT03758105Transcranial Direct Current Stimulation (tDCS) Cost-utility-analysis in Medical Care on Depressive Episode With One Drug Therapy Failure.
depression · FranceNA

NCT02841605Enteric Nervous System in Alzheimer Disease
alzheimers · FranceNA

NCT00873470Wolff-Parkinson-White Syndrome Anterograde Refractory Period of Accessory Duct
parkinsons · FranceNA

NCT03230526Identification of a Biomarker Predictive of Evolution of Parkinson Disease
parkinsons · FrancePHASE2

NCT02236260Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation
parkinsons · FranceNA

NCT04857788Program of Digital Accompaniment to Optimize Homework Performances and Increase Familial Quality of Life in 9 to 16 Years Children With ADHD
adhd · FranceNA

NCT00872443Interest of Occlusion of Permeable Foramen Ovale After a Cryptogenic Cerebrovascular Accident (CVA)
stroke · FranceCOMPLETED

NCT03754166Feasibility of Constraint-induced Therapy Combined With Visual-spatial Cueing Strategy in Patients With Acute Stroke
stroke · FranceNA

NCT04358042PSYCHIATRIC Disorders and Covid-19
other_psychiatry · FranceTERMINATED

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →